Shumpei Ishikawa Selected Research

Shumpei Ishikawa Research Topics

Disease

54	Neoplasms (Cancer) 04/2024 - 02/2003
10	Stomach Neoplasms (Stomach Cancer) 05/2023 - 10/2011
8	Adenocarcinoma 05/2024 - 10/2005
7	Adenocarcinoma of Lung 04/2023 - 12/2005
7	Neoplasm Metastasis (Metastasis) 02/2023 - 02/2006
7	Pancreatic Neoplasms (Pancreatic Cancer) 01/2021 - 10/2011
6	Lung Neoplasms (Lung Cancer) 04/2023 - 03/2003
5	Carcinogenesis 01/2022 - 02/2003
5	Carcinoma (Carcinomatosis) 04/2014 - 04/2009
4	Inflammation (Inflammations) 12/2023 - 06/2004
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 03/2024 - 03/2005
3	Glioma (Gliomas) 01/2019 - 01/2004
2	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 04/2024 - 03/2024
2	Interstitial Cystitis (Interstitial Cystitis, Chronic) 11/2023 - 01/2019
2	Hypoxia (Hypoxemia) 11/2021 - 04/2007
2	Autoimmune Diseases (Autoimmune Disease) 10/2020 - 12/2018
2	Adenocarcinoma in Situ 06/2020 - 07/2014
2	Squamous Cell Carcinoma of Head and Neck 01/2019 - 02/2017
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 12/2018 - 01/2012
2	Esophageal Squamous Cell Carcinoma 02/2015 - 02/2014
2	Hepatocellular Carcinoma (Hepatoma) 01/2014 - 02/2003
2	Malaria 11/2011 - 06/2004
2	Glioblastoma (Glioblastoma Multiforme) 07/2011 - 01/2004
1	Psoriasis (Pustulosis Palmaris et Plantaris) 12/2023
1	Hyperplasia 12/2023
1	Bites and Stings (Sting) 11/2023
1	Cystitis 11/2023
1	Pelvic Pain 11/2023
1	Cholangiocarcinoma 10/2022
1	Meningioma (Meningiomas) 01/2022
1	Chromosomal Instability (Chromosome Stability) 01/2022
1	Acquired Immunodeficiency Syndrome (AIDS) 01/2022

Drug/Important Bio-Agent (IBA)

14	Proteins (Proteins, Gene)FDA Link 03/2024 - 02/2003
11	DNA (Deoxyribonucleic Acid)IBA 11/2023 - 01/2004
7	Biomarkers (Surrogate Marker)IBA 05/2023 - 04/2014
5	RNA (Ribonucleic Acid)IBA 12/2023 - 11/2016
5	AntigensIBA 01/2023 - 01/2017
5	Messenger RNA (mRNA)IBA 01/2021 - 10/2003
5	OligonucleotidesIBA 12/2007 - 02/2003
4	Immune Checkpoint InhibitorsIBA 04/2024 - 02/2017
4	AntibodiesIBA 01/2023 - 01/2017
4	Cadherins (E-Cadherin)IBA 10/2022 - 02/2013
3	human ERBB2 proteinIBA 01/2022 - 09/2010
3	LigandsIBA 01/2020 - 01/2008
3	VimentinIBA 02/2013 - 11/2010
3	ErbB Receptors (EGF Receptor)IBA 11/2010 - 04/2007
3	Indicators and Reagents (Reagents)IBA 11/2010 - 12/2005
2	Colloids (Colloid)IBA 05/2024 - 06/2020
2	B7-H1 AntigenIBA 03/2024 - 12/2023
2	Proline (L-Proline)FDA Link 12/2023 - 01/2019
2	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 04/2023 - 02/2017
2	Eosine Yellowish-(YS) (Eosin)IBA 02/2023 - 01/2022
2	Hematoxylin (Haematoxylon)IBA 02/2023 - 01/2022
2	EpitopesIBA 01/2023 - 12/2018
2	Nucleic AcidsIBA 01/2023 - 10/2022
2	Immunoconjugates (Immunoconjugate)IBA 01/2023 - 01/2022
2	silicon phthalocyanineIBA 12/2022 - 01/2022
2	CateninsIBA 01/2020 - 10/2011
2	Formaldehyde (Formol)FDA Link 01/2020 - 02/2017
2	GlypicansIBA 11/2017 - 02/2003
2	ClaudinsIBA 09/2016 - 10/2011
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 02/2015 - 02/2003
2	Cisplatin (Platino)FDA LinkGeneric 02/2014 - 11/2010
2	Membrane Proteins (Integral Membrane Proteins)IBA 06/2013 - 04/2009
2	Complementary DNA (cDNA)IBA 01/2012 - 10/2005
2	EnzymesIBA 11/2011 - 06/2004
1	StreptavidinIBA 02/2024
1	Biotin (Vitamin H)FDA Link 02/2024
1	Lysophosphatidic Acid ReceptorsIBA 12/2023
1	Imiquimod (Aldara)FDA LinkGeneric 12/2023
1	DefensinsIBA 12/2023
1	InterleukinsIBA 12/2023
1	Nucleotide AptamersIBA 11/2023
1	Immunologic Factors (Immunomodulators)IBA 11/2023
1	InterferonsIBA 11/2023
1	matrigelIBA 04/2023
1	osteoblast cadherinIBA 02/2023
1	Immunoglobulins (Immunoglobulin)IBA 01/2023
1	Therapeutic UsesIBA 01/2023
1	Cys-ZHER2-342 affibodyIBA 12/2022
1	Small Cytoplasmic RNAIBA 11/2022
1	Aspartate-tRNA LigaseIBA 10/2022
1	Interferon-gamma (Interferon, gamma)IBA 10/2022
1	AcidsIBA 01/2022
1	NucleotidesIBA 01/2022
1	iminobiotinIBA 01/2022
1	Forkhead Box Protein M1IBA 01/2022
1	Transcription Factors (Transcription Factor)IBA 01/2022
1	ApelinIBA 11/2021
1	AutoantigensIBA 10/2020
1	RibonucleoproteinsIBA 10/2020
1	Trefoil Factor-1IBA 06/2020
1	AgarIBA 06/2020

Therapy/Procedure

8	Therapeutics 02/2024 - 11/2016
5	Drug Therapy (Chemotherapy) 01/2022 - 01/2004
3	Immunotherapy 10/2020 - 01/2017
2	Precision Medicine 01/2022 - 01/2018
2	Nephroureterectomy 06/2014 - 04/2014
1	Intravesical Administration 11/2023
1	Molecular Targeted Therapy 06/2020